Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers
Clinical trial NCT04403685 · TERMINATED
Trial details
- NCT number
- NCT04403685
- Sponsor
- Beneficência Portuguesa de São Paulo
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-08
- Primary completion
- 2020-07-08
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.